---
document_datetime: 2025-04-03 10:39:05
document_pages: 6
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/litak-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
document_name: litak-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
version: success
processing_time: 4.108715
conversion_datetime: 2025-12-20 01:18:01.507368
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## Litak

Procedural steps taken and scientific information after the authorisation

| Application number   | Scope                                                                                                             | Opinion/ Notification 1 issued on   | Commission Decision Issued 2 / amended on   | Product Information affected 3   | Summary                                                                                                                                  |
|----------------------|-------------------------------------------------------------------------------------------------------------------|-------------------------------------|---------------------------------------------|----------------------------------|------------------------------------------------------------------------------------------------------------------------------------------|
| PSUSA/787/2 02402    | Periodic Safety Update EU Single assessment - cladribine (apart from products with multiple sclerosis indication) | 17/10/2024                          | 19/12/2024                                  | SmPC                             | Refer to Scientific conclusions and grounds recommending the variation to terms of the Marketing Authorisation(s)' for PSUSA/787/202402. |
| IA/0022/G            | This was an application for a group of variations.                                                                | 14/07/2023                          | n/a                                         |                                  |                                                                                                                                          |

1  Notifications are issued for type I variations and Article 61(3) notifications (unless part of a group including a type II variation or extension application or a worksharing application). Opinions are issued for all other procedures.

2  A Commission decision (CD) is issued for procedures that affect the terms of the marketing authorisation (e.g. summary of product characteristics, annex II, labelling, package leaflet). The CD is issued within two months of the opinion for variations falling under the scope of Article 23.1a(a) of Regulation (EU) No. 712/2012, or within one year for other procedures.

3  SmPC (Summary of Product Characteristics), Annex II, Labelling, PL (Package Leaflet).

<!-- image -->

<!-- image -->

<div style=\"page-break-after: always\"></div>

|         | A.4 - Administrative change - Change in the name and/or address of a manufacturer or an ASMF holder or supplier of the AS, starting material, reagent or intermediate used in the manufacture of the AS or manufacturer of a novel excipient A.5.b - Administrative change - Change in the name and/or address of a manufacturer/importer of the finished product, including quality control sites (excluding manufacturer for batch release) B.II.b.5.b - Change to in-process tests or limits applied during the manufacture of the finished product - Addition of a new test(s) and limits B.II.e.7.a - Change in supplier of packaging components or devices (when mentioned in the dossier) - Deletion of a supplier B.II.e.7.b - Change in supplier of packaging components or devices (when mentioned in the dossier) - Replacement or addition of a supplier   |            |     |
|---------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|
| IB/0021 | B.II.b.1.f - Replacement or addition of a manufacturing site for part or all of the manufacturing process of the FP - Site where any manufacturing operation(s) take place, except batch release, batch control, and secondary packaging, for sterile medicinal products (including those that are aseptically manufactured) excluding biological/ immunological medicinal products                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    | 07/07/2023 | n/a |
| IB/0020 | B.II.b.3.a - Change in the manufacturing process of the finished or intermediate product - Minor change in the manufacturing process                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   | 04/04/2022 | n/a |

<div style=\"page-break-after: always\"></div>

| PSUSA/787/2 02102   | Periodic Safety Update EU Single assessment - cladribine (apart from products with multiple sclerosis indication)                                                                                                                                                                                                                                                                                                                                                                     | 30/09/2021   | n/a   | PRAC Recommendation - maintenance   |
|---------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|-------|-------------------------------------|
| PSUSA/787/2 01802   | Periodic Safety Update EU Single assessment - cladribine (apart from products with multiple sclerosis indication)                                                                                                                                                                                                                                                                                                                                                                     | 31/10/2018   | n/a   | PRAC Recommendation - maintenance   |
| IA/0018             | A.7 - Administrative change - Deletion of manufacturing sites                                                                                                                                                                                                                                                                                                                                                                                                                         | 18/09/2018   | n/a   |                                     |
| IA/0017/G           | This was an application for a group of variations. B.I.a.1.f - Change in the manufacturer of AS or of a starting material/reagent/intermediate for AS - Changes to quality control testing arrangements for the AS -replacement or addition of a site where batch control/testing takes place B.I.b.2.a - Change in test procedure for AS or starting material/reagent/intermediate - Minor changes to an approved test procedure B.I.c.1.a - Change in immediate packaging of the AS | 04/09/2018   | n/a   |                                     |
| II/0015             | B.II.e.1.a.3 - Change in immediate packaging of the finished product - Qualitative and quantitative composition - Sterile medicinal products and biological/immunological medicinal products                                                                                                                                                                                                                                                                                          | 05/07/2018   | n/a   |                                     |
| IA/0014/G           | This was an application for a group of variations. A.5.b - Administrative change - Change in the name                                                                                                                                                                                                                                                                                                                                                                                 | 15/05/2018   | n/a   |                                     |

<div style=\"page-break-after: always\"></div>

|                   | and/or address of a manufacturer/importer of the finished product, including quality control sites (excluding manufacturer for batch release) B.II.b.2.a - Change to importer, batch release arrangements and quality control testing of the FP - Replacement/addition of a site where batch control/testing takes place B.II.b.3.a - Change in the manufacturing process of the finished or intermediate product - Minor change in the manufacturing process B.II.b.5.b - Change to in-process tests or limits applied during the manufacture of the finished product - Addition of a new test(s) and limits B.II.d.1.c - Change in the specification parameters and/or limits of the finished product - Addition of a new specification parameter to the specification with its corresponding test method   |            |            |                                  |                                   |
|-------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|----------------------------------|-----------------------------------|
| IB/0013           | C.I.z - Changes (Safety/Efficacy) of Human and Veterinary Medicinal Products - Other variation                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                | 15/01/2018 | 07/03/2018 | SmPC, Annex II, Labelling and PL |                                   |
| PSUSA/787/2 01502 | Periodic Safety Update EU Single assessment - cladribine (apart from products with multiple sclerosis indication)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             | 08/10/2015 | n/a        |                                  | PRAC Recommendation - maintenance |
| IAIN/0012         | C.I.8.a - Introduction of or changes to a summary of Pharmacovigilance system - Changes in QPPV (including contact details) and/or changes in the PSMF location                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               | 02/07/2015 | n/a        |                                  |                                   |
| N/0010            | Minor change in labelling or package leaflet not                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              | 02/08/2013 | 07/03/2018 | PL                               |                                   |

<div style=\"page-break-after: always\"></div>

|         | connected with the SPC (Art. 61.3 Notification)                                                                                                                 |            |            |                                  |                                                                                                                                                                                                                                                       |
|---------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|----------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| IA/0009 | IA_01_Change in the name and/or address of the marketing authorisation holder IA_05_Change in the name and/or address of a manufacturer of the finished product | 28/05/2009 | n/a        | SmPC, Annex II, Labelling and PL |                                                                                                                                                                                                                                                       |
| R/0008  | Renewal of the marketing authorisation.                                                                                                                         | 22/01/2009 | 27/03/2009 | SmPC, Annex II, Labelling and PL | The overall risk/benefit for remains favourable and the Marketing Authorisation for Litak in the treatment of Hairy Cell Leukaemia can be renewed with unlimited validity. Periodic Safety Assessment reports should be provided on a 3 yearly basis. |
| IA/0007 | IA_38_a_Change in test procedure of finished product - minor change to approved test procedure                                                                  | 12/02/2008 | n/a        |                                  |                                                                                                                                                                                                                                                       |
| IA/0006 | IA_38_a_Change in test procedure of finished product - minor change to approved test procedure                                                                  | 07/06/2006 | n/a        |                                  |                                                                                                                                                                                                                                                       |
| IA/0005 | IA_13_a_Change in test proc. for active substance - minor change                                                                                                | 07/06/2006 | n/a        |                                  |                                                                                                                                                                                                                                                       |
| IA/0004 | IA_08_b_01_Change in BR/QC testing - repl./add. manuf. responsible for BR - not incl. BC/testing                                                                | 01/08/2005 | n/a        | Annex II and PL                  |                                                                                                                                                                                                                                                       |
| IA/0003 | IA_08_a_Change in BR/QC testing - repl./add. of batch control/testing site                                                                                      | 01/08/2005 | n/a        |                                  |                                                                                                                                                                                                                                                       |
| N/0002  | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                | 11/11/2004 | n/a        | Labelling                        |                                                                                                                                                                                                                                                       |
| IA/0001 | IA_07_a_Replacement/add. of manufacturing site:                                                                                                                 | 14/07/2004 | n/a        |                                  |                                                                                                                                                                                                                                                       |

<div style=\"page-break-after: always\"></div>

| Secondary packaging site   |
|----------------------------|